Company Monitoring Page for Biogen

latest headlines for company on cafepharma

Sage, Biogen's tremor drug hits goal, but 38% of people drop out
Fierce Biotech
Mon, 04/12/21 - 10:36 am
Tags:
SAGE Therapeutics, Biogen, essential tremor, SAGE-324, side effects, clinical trials
Biogen adds a late-stage prospect to its growing biosimilar business
BioPharma Dive
Thu, 04/8/21 - 07:44 pm
Tags:
Biogen, Actemra, anti-inflammatories, biosimilars, COVID-19
FDA grew too close to Biogen during Alzheimer’s drug development, doctors say
Pharmaforum
Thu, 04/1/21 - 10:51 am
Tags:
FDA, Biogen, drug development, aducanumab, Alzheimer's disease
FDA advisers reassert case against approval of Biogen's Alzheimer's drug
BioPharma Dive
Wed, 03/31/21 - 10:55 pm
Tags:
Biogen, FDA, Alzheimer's disease, aducanumab
5 FDA approval decisions to watch in the second quarter
BioPharma Dive
Mon, 03/29/21 - 11:16 pm
Tags:
FDA, Biogen, aducanumab, Acadia Pharmaceuticals, pimavanserin, AstraZeneca, vaccines, COVID-19, Sanofi, Avalglucosidase alfa, Pfizer, pneumococcal disease
Biogen's Aducanumab: A Look at the Drug’s History and Recent Updates
BioSpace
Sat, 03/27/21 - 12:14 pm
Tags:
Biogen, Eisai, aducanumab, Alzheimer's disease
Big pharma’s key catalysts in the second quarter
EP Vantage
Wed, 03/24/21 - 10:04 am
Tags:
Biogen, Alzheimer's disease, aducanumab, Sanofi, breast cancer, FDA
Biogen outlines 10M-patient opportunity for Alzheimer's drug in US
Biopharma Reporter
Tue, 03/16/21 - 10:48 pm
Tags:
Biogen, Alzheimer's disease, aducanumab
Clarivate Drugs to Watch Report Highlights Four Likely Blockbusters Among Drugs Launching in 2021
PR Newswire
Tue, 03/9/21 - 10:45 am
Tags:
Clarivate, Biogen, Eisai, aducanumab, UCB Pharma, bimekizumab, Relugolix, Pfizer, Takeda, Myovant, vericiguat, Bayer, Merck
Biogen to build gene therapy manufacturing center in North Carolina
Marketwatch
Thu, 03/4/21 - 09:50 am
Tags:
Biogen, gene therapy, North Carolina, drug manufacturing, RTP
Where Will Biogen Be in 5 Years?
Motley Fool
Tue, 02/23/21 - 10:40 am
Tags:
Biogen, aducanumab, Alzheimer's disease
Pharma’s pipeline continues to provide drama as investors look beyond COVID in Q4
Pharmaforum
Fri, 02/19/21 - 10:33 am
Tags:
pharma industry, R&D, pandemic, earnings, COVID-19, Biogen, GW Pharma, Jazz Pharmaceuticals, GSK, Merck KGaA
A safer Alzheimer's drug than Biogen's aducanumab? Denali-WashU drug shows better profile in mice
Fierce Biotech
Thu, 02/18/21 - 11:04 am
Tags:
Alzheimer's disease, Denali Therapeutics, Biogen, aducanumab, HAE-4
Former Biogen CEO Takes the Helm at Editas Medicine
BioSpace
Mon, 02/8/21 - 10:25 pm
Tags:
Biogen, Editas Medicine, James Mullen, Pharma CEOs
Biogen laser-focused on Alzheimer's drug as rest of business falters
BioPharma Dive
Wed, 02/3/21 - 10:55 pm
Tags:
Biogen, earnings, aducanumab, Alzheimer's disease
Biogen tosses out Parkinson's hopeful cinpanemab, pays $75M for its syn
Fierce Biotech
Wed, 02/3/21 - 10:53 am
Tags:
Biogen, earnings, Parkinson's Disease, cinpanemab
FDA extends review period for Biogen's Alzheimer's drug
Reuters
Fri, 01/29/21 - 10:06 am
Tags:
Biogen, Eisai, FDA, aducanumab, Alzheimer's disease
Aducanumab tops 2021’s biggest potential launches
EP Vantage
Mon, 01/18/21 - 01:04 pm
Tags:
drug launches, Biogen, Eisai, aducanumab, efgartigimod, Argenx, Evrenzo, FibroGen, Astellas, AstraZeneca, Leqvio, Novartis, UCB Pharma, bimekizumab, Ascendis Pharma, Bluebird Bio, Bristol-Myers Squibb, ide-cel, liso-cel, AXS-05, Axsome Therapeutics, voclosporin, Aurinia
10 key clinical trials to watch in the first half of 2021
BioPharma Dive
Sun, 01/17/21 - 05:01 pm
Tags:
clinical trials, Novavax, AstraZeneca, JNJ, vaccines, COVID-19, Biomarin, Amgen, Merck, Pfizer, Roche, SAGE Therapeutics, Biogen, Vertex Pharmaceuticals
Here's the Top FDA Decision to Watch in 2021
Motley Fool
Sun, 01/17/21 - 04:56 pm
Tags:
FDA, Biogen, aducanumab, Alzheimer's disease

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.